Search for: "Clinical Data, Inc."
Results 481 - 500
of 997
Sort by Relevance
|
Sort by Date
27 Aug 2015, 12:51 pm
Thomas Fleming, a statistician and “trialist,” who had served on the data safety and monitoring board of the clinical trial at issue.[2] Fleming took the rather extreme view that a clinical trial that “fails” to meet its primary pre-stated end point at the conventional p-value of less than 5 percent is an abject failure and provides no demonstration of any claim of efficacy. [read post]
16 Aug 2015, 10:58 am
"Most of the data we have are from the clinical trials, and you can't necessarily go by the clinical trial data in looking at complications because obviously some women in real life practice aren't following up,” Micks said, “so we don't really know if they have a malposition of their coils. [read post]
16 Aug 2015, 8:49 am
This risk may be slightly greater for Salmonella and Yersinia-associated arthritis than with Campylobacter, but more research is required to clarify this.[14] Irritable Bowel Syndrome A recently-published study surveyed the extant scientific literature and noted that post-infectious irritable bowel syndrome (PI-IBS) is a common clinical phenomenon first-described over five decades ago.[15] The Walkerton Health Study further notes that: Between 5% and 30% of patients who suffer an acute… [read post]
13 Aug 2015, 10:56 am
Biogen Idec, Inc. is a case involving a brand-name pharmaceutical product which held that design defect claims against drug manufacturers are preempted as a matter of law. [read post]
10 Aug 2015, 8:15 am
& Order, Amarin Pharma, Inc., et al. v. [read post]
5 Aug 2015, 9:01 pm
The case, Spokeo, Inc. v. [read post]
9 Jul 2015, 11:42 am
Covidien Holdings, Inc., et al., 2015 U.S. [read post]
9 Jul 2015, 7:20 am
The manufacturer has better safety/effectiveness data for HSDD, but the testimony at the panel hearing made clear that significant off-label use for purposes of sexual gratification would also occur:A final concern regarding flibanserin relates to its likely use in clinical practice, and this was a major issue for the committee. [read post]
8 Jul 2015, 4:30 am
Energizer Holdings, Inc., 962 F. [read post]
4 Jul 2015, 3:39 pm
Allergan, Inc., Civ. [read post]
30 Jun 2015, 6:32 am
Medtronic, Inc., 552 U.S. 312 (2008)) between §510k “substantial equivalence” clearance and premarket approval. [read post]
26 Jun 2015, 1:08 pm
Kingdomware Technologies, Inc. v. [read post]
25 Jun 2015, 5:29 pm
Robertson, a plan participant under an employer-sponsored health benefits plan established by Defendant Stallion Oilfield Holdings, Inc. [read post]
16 Jun 2015, 7:22 am
Alcon Labs., Inc., 201 F. [read post]
15 Jun 2015, 6:24 pm
She produced the documentary film “Orgasm, Inc. [read post]
15 Jun 2015, 3:57 am
” Leeper agreed that clinical tests are necessary to confirm the causal link between PPI use and heart attacks, but said that the Stanford data analysis was sufficient to make the Food and Drug Administration (FDA) aware of the connection between popular heartburn medications and heart health risks. [read post]
5 Jun 2015, 7:32 am
Braun, 14-1123, and Wal-Mart Stores, Inc. v. [read post]
4 Jun 2015, 10:02 pm
Such validation data may allow operators to accept some trace levels and avoid the pitfall of chasing molecules around a plant when such levels are shown not to affect the final product. [read post]
3 Jun 2015, 6:16 am
Allergan, Inc., 2015 U.S. [read post]
26 May 2015, 7:42 am
This one concerns how to report pharmacogenomic data to the Agency. [read post]
